Adrian Skelly

Merrion Road
Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Correction to: Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis.

Correction to: Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis.

Journal: Advances in therapy
Published: November 30, 2022

Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis.

Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis.

Journal: Advances in therapy
Published: March 03, 2022

Treat and Extend Treatment Interval Patterns with Anti-VEGF Therapy in nAMD Patients.

Treat and Extend Treatment Interval Patterns with Anti-VEGF Therapy in nAMD Patients.

Journal: Vision (Basel, Switzerland)
Published: July 04, 2019

SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States.

SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States.

Journal: Ophthalmology. Retina
Published: May 28, 2019

The economic and humanistic burden of patients in receipt of current available therapies for nAMD.

The economic and humanistic burden of patients in receipt of current available therapies for nAMD.

Journal: Journal of comparative effectiveness research
Published: September 22, 2018

Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence.

Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence.

Journal: Ophthalmology. Retina
Published: December 21, 2017

Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia.

Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia.

Journal: Advances in therapy
Published: May 03, 2017

Erratum to: The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis.

Erratum to: The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis.

Journal: Advances in therapy
Published: April 19, 2017

Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

Journal: Eye (London, England)
Published: February 25, 2017

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom.

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom.

Journal: Advances in therapy
Published: November 24, 2016

The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis.

The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis.

Journal: Advances in therapy
Published: November 15, 2016

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

Journal: Eye (London, England)
Published: January 25, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026